WO2023012722 - miRNA-BASED COMPOSITIONS AND METHODS OF USE THEREOF
National phase entry:
Publication Number
WO/2023/012722
Publication Date
09.02.2023
International Application No.
PCT/IB2022/057268
International Filing Date
04.08.2022
Title **
[English]
miRNA-BASED COMPOSITIONS AND METHODS OF USE THEREOF
[French]
COMPOSITIONS À BASE D'ARNMI ET MÉTHODES D'UTILISATION
Applicants **
LEADERMED CHAMPION LIMITED
Inventors
YUAN, Jie Jenny
JIANG CHEN, Qiao Joanne
SUN, Peiwen
Priority Data
63/230,502
06.08.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2953 | |
| EPO | Filing, Examination, Granting | 30341 | |
| Japan | Filing, Examination, Granting | 3232 | |
| South Korea | Filing, Examination, Granting | 4462 | |
| USA | Filing, Examination, Granting | 11940 |
Total:
52,928
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
This disclosure relates to agents and methods for treating a condition or disorder associated with collagen deficiency, for preventing or treating a skin disease or disorder or for improving a skin condition.[French]
La présente divulgation concerne des agents et des méthodes pour traiter un état pathologique ou un trouble associé à une déficience en collagène, pour prévenir ou traiter une maladie ou un trouble cutané ou pour améliorer un état pathologique cutané.